Company: PFSA
Filing Date: 2025-05-15
Form Type: 424B3
Source: 0001213900-25-044417
Chunk: 4

Company: Profusa, Inc.
Filing Date: 2025-05-15
Form: 424B3
Chunk 4
---
 approximately $1.9million as of March21, 2025, this would have amounted to approximately $12.21 per issued and outstanding public share. If a public stockholder exercises its redemption rights in full, then it will be electing to exchange its public shares for cash and will no longer own public shares. See “Special Meeting of NorthView Holders — Redemption Rights”in the accompanying proxy statement/prospectus for a detailed description of the procedures to be followed if you wish to redeem your public shares for cash. Notwithstanding the foregoing, a public stockholder, together with any affiliate of such public stockholder or any other person with whom such public stockholder is acting in concert or as a “group” (as defined in Section 13(d)(3) of the U.S. Securities Exchange Act of 1934, as amended (“Exchange Act”)), will be restricted from redeeming its public shares with respect to more than an aggregate of 15% of the public shares. Accordingly, if a public stockholder, alone or acting in concert or as a group, seeks to redeem more than 15% of the public shares without the consent of NorthView, then any such shares in excess of that 15% limit would not be redeemed for cash. The consummation of the transactions contemplated by the Merger Agreement, including the occurrence of the Closing, is subject to the satisfaction or waiver of certain other closing conditions as described in the accompanying proxy statement/prospectus under the section entitled “Proposal 1 — The Business Combination Proposal — Merger Agreement — Conditions to Closing”. There can be no assurance that the parties to the Merger Agreement would waive any such provision of the Merger Agreement or that the transactions contemplated by the Merger Agreement, including the Closing, will be consummated. Material Financing Transactions: Since the completion of NorthView’s IPO in December 2021, NorthView has not completed any material financing transactions. However, as of the expected Closing Date of the Business Combination, the Sponsor will have lent to NorthView an estimated $1.9million pursuant to interest -freeloans, including for funds deposited in the Trust Account in connection with extensions of the deadline by which NorthView had to consummate its initial business combination. These loans are due to be repaid at Closing, but are expected to be converted into shares of New Profusa Common Stock at a price of $2.22 per share. In connection with the Business Combination, the parties intend to consummate a financing, pursuant